Foreign Investment Promotion Board (FIPB) today cleared FDI proposal of Mylan Laboratories entailing a capital inflow of Rs 4,960 crore.
Famy`s Generic Levonorgestrel & Ethinyl Estradiol Approved in US For Contraception
Famy`s Generic Desogestrel and Ethinyl Estradiol Approved in US For Contraception
Famy`s Generic Drospirenone & Ethinyl Estradiol Approved in US For Contraception
Mylan (MYL) Ups Bid for Perrigo (PRGO) to $32.7B, As M&A Hungry Hippos Continues
How Abbott (ABT) is Reaping Rewards FromTeva (TEVA)`s Bid for Mylan (MYL)
Famy`s Generic Ethinyl Estradiol and Norethindrone (0.035MG and 0.4MG) Approved in USA For Contraception
Famy`s Generic Norethindrone Acetate; Ethinyl Estradiol (1.5Mg; 0.03Mg) Approved in USA for Contraception